Last week, the BDBI alumni Marta Ibáñez and Aina Montalban were the last guest speakers of the term of Introduction to Bioinformatics talks.
Both graduated in 2020. While in the BDBI, Marta Ibáñez did her internship at Cambridge, where she studied pregnancy aetiology. Aina Montalban chose the Josep Carreras Leukaemia Research Institute to study cancer epigenetics.
After graduating, Marta did two master’s degrees (Genetics and Genomics at UB and Translational Biomedical Research at VHIR), and Aina started working as a Bioinformatics specialist at Hospital Clínic de Barcelona.
During her presentation, Marta Ibañez spoke about the PhD she began this year at VHIR, which focuses on liver diseases. She explained to the students the path she followed before enrolling in the PhD journey.
Aina Montalban shared her day-a-day life at a clinical lab in the Hospital Clínic de Barcelona. She explained how a lab processes and analyzes patients’ samples to obtain a conclusive diagnosis and delve into the data flow features they use. She also pointed out briefly about the master’s in Data Science she is currently studying at UPC.
The alumni mentioned the most helpful BDBI courses for their professional experiences and which bits of knowledge they acquired during the degree they still use on a daily basis.
Last week, Blanca Fabian, ESCI-UPF alumni, came to our Statistics class to talk about how she applies statistics in her career and how it is helpful in the business field, using data-driven evidence to support the company’s strategic marketing decisions and making use of the inferential statistics we have been learning in class.
Lucía Hernández, alumni del GNMI de la promoción 2020, explica cómo fue su experiencia en la Ofecome de Marruecos después de su paso por el programa de becas de ICEX-CECO. El plazo para presentarse a la convocatoria de este año termina el próximo 30 de marzo.
Gianluca Galimberti es un empresario de dilatada trayectoria en el mundo de los negocios, con alma emprendedora y que, fruto de esa experiencia, en 2011, decidió crear COBAPHARMA, una empresa que ha tenido un crecimiento vertiginoso desde entonces.
Leave a message